Cargando…

VEGF Promoter Polymorphism Confers an Increased Risk of Pulmonary Arterial Hypertension in a Chinese Population

PURPOSE: Evidence on the contribution of genes to the hereditary predisposition to pulmonary arterial hypertension (PAH) is limited. MATERIALS AND METHODS: In this study, we hypothesized that single nucleotide variants in vascular endothelial growth factor (VEGF) gene may alter gene function and exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuo, Yufeng, Zeng, Qingchun, Zhang, Peng, Li, Guoyang, Xie, Qiang, Cheng, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290009/ https://www.ncbi.nlm.nih.gov/pubmed/28120560 http://dx.doi.org/10.3349/ymj.2017.58.2.305

Ejemplares similares

The impact of pulmonary arterial hypertension-targeted therapy on survival in Chinese patients with idiopathic pulmonary arterial hypertension
por: Zeng, Wei-Jie, et al.
Publicado: (2012)

Role for Functional SOD2 Polymorphism in Pulmonary Arterial Hypertension in a Chinese Population
por: Xu, Ming, et al.
Publicado: (2017)

Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis
por: Papaioannou, Andriana I, et al.
Publicado: (2009)

Diagnostic values of serum BNP, PTX3, and VEGF in acute pulmonary embolism complicated by pulmonary artery hypertension and their correlations with severity of pulmonary artery hypertension
por: Zheng, Qinghou, et al.
Publicado: (2023)

Idiopathic Pulmonary Arterial Hypertension and Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Chinese Children: Similarities, Differences, and Prognostic Factors
por: Gu, Li, et al.
Publicado: (2020)

CCR5 Promoter Polymorphisms Associated With Pulmonary Tuberculosis in a Chinese Han Population
por: Liu, Shuyuan, et al.
Publicado: (2021)

Role of macrophages in pulmonary arterial hypertension
por: Zhang, Meng-Qi, et al.
Publicado: (2023)

Aggrecan accumulates at sites of increased pulmonary arterial pressure in idiopathic pulmonary arterial hypertension
por: van der Have, Oscar, et al.
Publicado: (2023)

t-plasminogen activator inhibitor-1 polymorphism in idiopathic pulmonary arterial hypertension
por: Katta, Sujana, et al.
Publicado: (2008)

2020 Chinese Expert-based Consensus on the Diagnosis and Treatment of Connective Tissue Disease Associated Pulmonary Arterial Hypertension
por: Zhao, Jiuliang, et al.
Publicado: (2021)

VEGF-C Gene Polymorphisms Increase Susceptibility to Rheumatoid Arthritis
por: Dai, Chengqian, et al.
Publicado: (2019)

FUT8-Mediated Core Fucosylation Promotes the Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension
por: Zhang, Wen, et al.
Publicado: (2023)

Atrial arrhythmias are associated with increased mortality in pulmonary arterial hypertension
por: Smith, Benjamin, et al.
Publicado: (2018)

Increased Lung Uric Acid Deteriorates Pulmonary Arterial Hypertension
por: Watanabe, Takanori, et al.
Publicado: (2021)

Pulmonary arterial wedge pressure increase during exercise in patients diagnosed with pulmonary arterial or chronic thromboembolic pulmonary hypertension
por: Müller, Julian, et al.
Publicado: (2023)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

Pulmonary Arterial Hypertension
por: Michelakis, Evangelos D., et al.
Publicado: (2007)

HMGB1 Promotes the Development of Pulmonary Arterial Hypertension in Rats
por: Sadamura-Takenaka, Yukari, et al.
Publicado: (2014)

Pri-microRNA-124 rs531564 polymorphism minor allele increases the risk of pulmonary artery hypertension by abnormally enhancing proliferation of pulmonary artery smooth muscle cells
por: Li, Quanzhong, et al.
Publicado: (2017)

Hypermethylation of dihydrofolate reductase promoter increases the risk of hypertension in Chinese
por: Xu, Guodong, et al.
Publicado: (2020)

Association between a Single Nucleotide Polymorphism in the 3′-UTR of ARHGEF18 and the Risk of Nonidiopathic Pulmonary Arterial Hypertension in Chinese Population
por: Li, Ding, et al.
Publicado: (2018)

Endothelial dysfunction in pulmonary arterial hypertension: an evolving landscape (2017 Grover Conference Series)
por: Ranchoux, Benoît, et al.
Publicado: (2017)

Study of the Association between VEGF Polymorphisms and the Risk of Coronary Artery Disease in Koreans
por: Ko, Eun-Ju, et al.
Publicado: (2022)

Pulmonary hypertension and pulmonary artery dissection
por: Corrêa, Ricardo de Amorim, et al.
Publicado: (2013)

Vascular toxicities with VEGF inhibitor therapies–focus on hypertension and arterial thrombotic events
por: Touyz, Rhian M., et al.
Publicado: (2018)

Meta-Analysis of Pulmonary Artery Denervation for Treatment of Pulmonary Hypertension
por: Zuo, Wanyun, et al.
Publicado: (2022)

Serum osteoprotegerin is increased and predicts survival in idiopathic pulmonary arterial hypertension
por: Condliffe, Robin, et al.
Publicado: (2012)

Increasing quality of life in pulmonary arterial hypertension: is there a role for nutrition?
por: Vinke, Paulien, et al.
Publicado: (2018)

Is pulmonary arterial hypertension associated with schistosomiasis distinct from pulmonary arterial hypertension associated with portal hypertension?
por: Graham, Brian B., et al.
Publicado: (2023)

Synemin promotes pulmonary artery smooth muscle cell phenotypic switch in shunt‐induced pulmonary arterial hypertension
por: Zhou, Jingjing
Publicado: (2022)

Vascular endothelial growth factor (VEGF) polymorphism rs3025039 and atherosclerosis among older with hypertension
por: Shimizu, Yuji, et al.
Publicado: (2022)

BMPR2 mutations and endothelial dysfunction in pulmonary arterial hypertension (2017 Grover Conference Series)
por: Frump, Andrea, et al.
Publicado: (2018)

Increased pulmonary artery diameter on chest computed tomography can predict borderline pulmonary hypertension
por: Lange, Tobias J., et al.
Publicado: (2013)

IMP3 promotes re‐endothelialization after arterial injury via increasing stability of VEGF mRNAhv
por: Zhou, Xinmiao, et al.
Publicado: (2022)

Pulmonary venous remodeling in COPD-pulmonary hypertension and idiopathic pulmonary arterial hypertension
por: Andersen, Kasper Hasseriis, et al.
Publicado: (2017)

Novel hub genes associated with pulmonary artery remodeling in pulmonary hypertension
por: Tan, Rubin, et al.
Publicado: (2022)

Cost Effectiveness of Bosentan for Pulmonary Arterial Hypertension: A Systematic Review
por: You, Ruxu, et al.
Publicado: (2018)

Pulmonary artery enlargement in schistosomiasis associated pulmonary arterial hypertension
por: Hoette, Susana, et al.
Publicado: (2015)

Pulmonary arterial hypertension: an update
por: Hoendermis, E. S.
Publicado: (2011)

Pulmonary arterial hypertension and pregnancy
por: Terek, Demet, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_up7ekieq10d34t01h26c99vlv5